Cruvinel Estela, Ogusuku Isabella, Cerioni Rosanna, Rodrigues Sirlene, Gonçalves Jéssica, Góes Maria Elisa, Alvim Juliana Morais, Silva Anderson Carlos, Lino Vanesca de Souza, Boccardo Enrique, Goulart Ernesto, Pereira Alexandre, Dariolli Rafael, Valadares Marcos, Biagi Diogo
PluriCell Biotech, São Paulo, Brazil.
Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.
SAGE Open Med. 2020 Oct 22;8:2050312120966456. doi: 10.1177/2050312120966456. eCollection 2020.
To establish a straightforward single-cell passaging cultivation method that enables high-quality maintenance of human induced pluripotent stem cells without the appearance of karyotypic abnormalities or loss of pluripotency.
Cells were kept in culture for over 50 passages, following a structured chronogram of passage and monitoring cell growth by population doubling time calculation and cell confluence. Standard procedures for human induced pluripotent stem cells monitoring as embryonic body formation, karyotyping and pluripotency markers expression were evaluated in order to assess the cellular state in long-term culture. Cells that underwent these tests were then subjected to differentiation into keratinocytes, cardiomyocytes and definitive endoderm to evaluate its differentiation capacity.
Human induced pluripotent stem cells clones maintained its pluripotent capability as well as chromosomal integrity and were able to generate derivatives from the three germ layers at high passages by embryoid body formation and high-efficient direct differentiation into keratinocytes, cardiomyocytes and definitive endoderm.
Our findings support the routine of human induced pluripotent stem cells single-cell passaging as a reliable procedure even after long-term cultivation, providing healthy human induced pluripotent stem cells to be used in drug discovery, toxicity, and disease modeling as well as for therapeutic approaches.
建立一种简单的单细胞传代培养方法,能够高质量地维持人诱导多能干细胞,且不会出现核型异常或多能性丧失。
按照结构化的传代时间表将细胞培养超过50代,并通过群体倍增时间计算和细胞汇合度监测细胞生长。评估人诱导多能干细胞监测的标准程序,如胚状体形成、核型分析和多能性标志物表达,以评估长期培养中的细胞状态。然后将经过这些测试的细胞诱导分化为角质形成细胞、心肌细胞和确定内胚层,以评估其分化能力。
人诱导多能干细胞克隆保持了其多能性以及染色体完整性,并且在高代次时能够通过胚状体形成以及高效直接分化为角质形成细胞、心肌细胞和确定内胚层,从三个胚层产生衍生物。
我们的研究结果支持人诱导多能干细胞单细胞传代作为一种可靠程序的常规应用,即使经过长期培养,也能提供健康的人诱导多能干细胞用于药物发现、毒性和疾病建模以及治疗方法。